Kunihiro Yamaoka Selected Research

Kunihiro Yamaoka Research Topics

Disease

51	Rheumatoid Arthritis 04/2022 - 11/2007
9	Herpes Zoster 04/2022 - 01/2016
8	Infections 04/2022 - 05/2013
8	Inflammation (Inflammations) 01/2022 - 01/2007
7	Immunoglobulin G4-Related Disease 01/2020 - 09/2015
6	Arthritis (Polyarthritis) 10/2022 - 01/2012
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 04/2011
3	Synovitis 01/2022 - 06/2012
3	COVID-19 02/2021 - 01/2020
3	Disease Progression 01/2021 - 04/2011
3	Rheumatic Diseases (Rheumatism) 01/2018 - 01/2016
3	Autoimmune Diseases (Autoimmune Disease) 09/2016 - 04/2013
2	Lymphadenopathy 01/2022 - 01/2016
2	Opportunistic Infections (Opportunistic Infection) 01/2021 - 11/2020
2	Dermatomyositis (Dermatopolymyositis) 01/2021 - 01/2012
2	Fever (Fevers) 12/2020 - 01/2018
2	Pneumonia (Pneumonitis) 11/2020 - 01/2020
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2018 - 01/2017
2	Pathologic Processes 09/2016 - 11/2013
2	Osteoarthritis 01/2016 - 05/2015
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2006 - 11/2005
1	Arthralgia (Joint Pain) 04/2022
1	Lupus Nephritis 02/2022
1	Psoriatic Arthritis 02/2022
1	Hyperferritinemia 01/2022
1	Ulcerative Colitis 01/2022
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2022
1	Hemoptysis 02/2021
1	Pulmonary Embolism 02/2021
1	Pulmonary Infarction 02/2021
1	Intracranial Vasospasm 01/2021
1	Bone Resorption 01/2021
1	Rhinitis 12/2020
1	Consciousness Disorders 12/2020
1	Pancreatitis 11/2020
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2018
1	Amyloidosis 01/2018
1	Lymphoma (Lymphomas) 01/2018

Drug/Important Bio-Agent (IBA)

14	tofacitinibIBA 02/2022 - 01/2012
11	Janus Kinase InhibitorsIBA 02/2022 - 01/2012
10	Methotrexate (Mexate)FDA LinkGeneric 02/2022 - 01/2007
9	CytokinesIBA 01/2022 - 11/2005
8	Immunoglobulin G (IgG)IBA 01/2020 - 09/2015
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2015
5	tocilizumab (atlizumab)FDA Link 01/2022 - 05/2014
5	AutoantibodiesIBA 01/2022 - 09/2016
4	GLPG0634IBA 04/2022 - 01/2022
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2015
4	upadacitinibIBA 01/2022 - 11/2020
4	Janus KinasesIBA 01/2022 - 01/2014
4	Antirheumatic Agents (DMARD)IBA 01/2021 - 01/2014
4	Interleukin-10 (Interleukin 10)IBA 10/2019 - 01/2012
4	Infliximab (Remicade)FDA Link 06/2016 - 08/2009
3	Adalimumab (Humira)FDA Link 02/2022 - 09/2013
3	Rituximab (Mabthera)FDA Link 02/2022 - 04/2011
3	Pharmaceutical PreparationsIBA 01/2018 - 11/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016 - 08/2009
3	Interleukin-4 (Interleukin 4)IBA 09/2015 - 11/2005
3	Interleukin-17 (Interleukin 17)IBA 01/2013 - 03/2011
2	C-Reactive ProteinIBA 01/2022 - 01/2018
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 03/2010
2	EnzymesIBA 11/2020 - 07/2018
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2006
2	GlucocorticoidsIBA 05/2018 - 09/2015
2	Biological ProductsIBA 11/2016 - 01/2014
2	3-benzoyl dopamine (MBDA)IBA 11/2016 - 05/2015
2	Collagen Type II (Type II Collagen)IBA 01/2015 - 01/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2012 - 11/2005
2	Dopamine (Intropin)FDA LinkGeneric 03/2011 - 02/2009
1	Prednisolone (Predate)FDA LinkGeneric 10/2022
1	SteroidsIBA 10/2022
1	omega-Chloroacetophenone (Mace)IBA 04/2022
1	Ferritins (Ferritin)IBA 01/2022
1	Anti-ribosomal P protein autoantibodiesIBA 01/2022
1	AnticoagulantsIBA 02/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	milk fat globuleIBA 01/2021
1	AntigensIBA 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020
1	AntibodiesIBA 01/2020
1	Ritonavir (Norvir)FDA Link 01/2020
1	Lopinavir FDA Link 01/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	Nucleic AcidsIBA 01/2020
1	Thiostrepton (Gargon)IBA 12/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019
1	Interleukin-8 (Interleukin 8)IBA 10/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	Immunoglobulin M (IgM)IBA 05/2018
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 05/2018
1	Immunoglobulin E (IgE)IBA 05/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018

Therapy/Procedure

10	Therapeutics 04/2022 - 04/2011
1	Mechanical Ventilators (Ventilator) 02/2021
1	Suction (Suction Drainage) 02/2021
1	Extracorporeal Membrane Oxygenation 11/2020
1	Aftercare (After-Treatment) 05/2018
1	Renal Dialysis (Hemodialysis) 01/2018